Share on

North America Atherectomy Devices Market Research Report - Segmented By Type, Application, End User & Country (the United States, Canada and Rest of North America) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2023 to 2028)

Published: March, 2023
ID: 6727
Pages: 145
Formats: report pdf report excel report power bi report ppt

North America Atherectomy Devices Market Size (2023 to 2028)

The size of the atherectomy devices market in North America is predicted to be worth USD 510.4 million by 2028 from USD 366.4 million in 2023, growing at a CAGR of 6.85% from 2023 to 2028.

North America is expected to experience a dominant position in the global atherectomy devices market during the forecast period due to the increasing adoption of advanced atherectomy procedures involving minimally invasive techniques to treat serious diseases. Also, a substantial geriatric population is more susceptible to peripheral artery disease (PAD). This scenario is advantageous for the market's development as the need for advanced atherectomy devices increases, encouraging the regional market's growth.

Factors such as increased accessibility to reimbursement for atherectomy technologies, acceptance of atherectomy systems by healthcare professionals, a large patient population with coronary heart and peripheral arterial disease, and an increasing number of trial clinics are expected to escalate the growth rate of the market. The major drivers for the North American region's dominance are the relevant reimbursement scenario and many FDA-approved devices. The elevating number of health disorders and the rising demand for more acceptable treatments and preventative measures have led to technological advancements in the medical industry. In addition, the escalating acceptance of minimal invasive atherectomy procedures is forecasted to boost the need for atherectomy devices. These variables fuel the demand for directional atherectomy devices and medical devices global existence in developed and developing markets.

Factors such as the stringent rules and regulations, the high adoption of other possible therapies, and the lack of well-trained surgeons to practice atherectomy procedures are predicted to hamper the advancement of the atherectomy devices market in the North American region over the foreseen period.

This research report on the North America Atherectomy Devices Market has been segmented and sub-segmented into the following categories:

By Type: 

  • Directional
  • Rotational
  • Orbital
  • Lateral

By Application: 

  • Peripheral
  • Cardiovascular
  • Neurovascular

By End User: 

  • Hospitals
  • Surgical Centers
  • Research Laboratories
  • Academic Institutes

By Country:  

  • The United States
  • Canada
  • Rest of North America

Geographically, North America is expected to retain a significant position in the global atherectomy devices market during the forecast period, owing to the apparent increasing use of enhanced minimally invasive surgical treatments utilizing minimally invasive approaches to treat critical conditions. In addition, the growing popularity of minimally invasive atherectomy operations is expected to augment the growth of atherectomy devices in the North American region. These factors contribute to the need for directed atherectomy devices and the global presence of medical devices in developed and developing markets. 

North America is expected to hold the highest share of the global atherectomy devices market during the forecast period. The regional market growth is driven by the expanding healthcare sector and the acceleration of research and development activities. The market for atherectomy devices in North America was studied in the United States, Canada, and Mexico. In addition, the popularity of minimally invasive atherectomy procedures will drive up demand for atherectomy devices. These factors contribute to the need for directed atherectomy devices and the global availability of medical devices in developed and developing markets.

The U.S. dominated the North American atherectomy devices market, and it is likely to continue its dominance throughout the forecast period. The market growth is fuelled by rising initiatives by various research institutes and organizations, the availability of advanced medical facilities and services, and favorable reimbursement policies. In addition, in 2018, the Centers for Disease Control and Prevention (CDC), a renowned United States public health organization, awarded funding to many health programs in the region. 

According to Roma Pahwa’s article, from 2020, over 610,000 people die of heart disease in the United States each year, accounting for one out of every four deaths. Coronary heart disease is the region’s most significant cause of mortality, killing more than 370,000 individuals each year. Every year, over 735,000 Americans suffer a heart attack. The demand for gadgets is increasing as the number of patients grows.

KEY MARKET PLAYERS:

Companies playing a dominant role in the North America atherectomy devices market profiled in this report are Bayer HealthCare, C. R. Bard, Inc., Cardinal Health (Cordis), Avinger, Inc., Boston Scientific Corporation, Straub Medical AG, St. Jude Medical, Cardiovascular Systems, Inc., and Spectranetics.

Please wait. . . . Your request is being processed

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000

Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM

Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!

REACH OUT TO US

Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: [email protected]

Click for Request Sample